{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-012382","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2022-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.748520+00:00","generated_at":"2026-06-24T22:04:06.690692+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Director Yun Yen resigns from Fulgent Genetics board and committees effective June 25, 2022","bullets":["Dr. Yen resigned from the Board, Audit, Compensation, and Nominating & Corporate Governance Committees.","Resignation effective June 25, 2022; no reason given other than personal decision.","No disagreement with company operations, policies, or practices cited in filing.","No replacement director or committee appointments announced."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-012382","json":"https://secwatch.observer/filing/0000950170-22-012382.json","markdown":"https://secwatch.observer/filing/0000950170-22-012382.md","text":"https://secwatch.observer/filing/0000950170-22-012382.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017022012382/0000950170-22-012382-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017022012382/flgt-20220625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:04:06.690692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90ac24dc25","claim":"Yun Yen resigned as Director at Fulgent Genetics, Inc..","evidence_excerpt":"On June 25, 2022, Yun Yen, M.D., Ph.D., F.A.C.P., notified the Board of Directors (the “Board”) of Fulgent Genetics, Inc. (the “Company”) of his decision to resign from the Board, the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee of the Board, effective as of June 25, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017022012382/0000950170-22-012382-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}